Expression of a D2 dopamine receptor antisense RNA in brain inhibits D2-mediated behaviors

Neurochemistry International

Volumn 31, Issue 4, 1997, Pages 571-580

  Weiss, Benjamin ^a   Davidkova, Genoveva ^a   Zhou, Long Wu ^a   Zhang, Sui Po ^a   Morabito, Mark ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; COMPLEMENTARY RNA; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; MESSENGER RNA; RECEPTOR SUBTYPE; OXIDOPAMINE; RNA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR MODIFICATION; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DNA TRANSCRIPTION; DOPAMINERGIC SYSTEM; EXPRESSION VECTOR; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BRAIN; CORPUS STRIATUM; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; INJECTION; METABOLISM; MOUSE STRAIN; NUCLEIC ACID PROBE; PHYSIOLOGY; ROTATION; STEREOTYPY;

ANIMALS; ANTISENSE ELEMENTS (GENETICS); BEHAVIOR, ANIMAL; BRAIN; CORPUS STRIATUM; INJECTIONS; MALE; MICE; MICE, INBRED STRAINS; OXIDOPAMINE; RECEPTORS, DOPAMINE D2; RNA; ROTATION; STEREOTYPED BEHAVIOR;

EID: 0030608861     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(97)00025-9     Document Type: Article

References (51)

1. Ann, D., Hasegawa, J., Ko, J.-L., Chen, S.-T. and Lee, N. and Loh, H. (1992) Specific reduction of δ-opioid receptor binding in transfected NG108-15 cells. J. Biol. Chem. 267, 7921-7926.
2. Arany, L, Zhang, X., Loh, H. H. and Lee, K M. (1992) Antisense proenkephalin cDNA transfecticn decreases opioid binding in NG 108-15 cells. Molec. Brain Res. 16, 295-302.
3. Battaglia, G., Norman, A. B., Hess, E. J. and Creese, I. (1986) Functional recovery of D1 dopamine receptor-mediated stimulation of rat striatal adenylate cyclase activity following irreversible receptor modification by N-ethoxy-carbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): evidence for spare receptors. Neurosci. Lett. 69, 290-295.
4. Bourson, A., Borroni, E., Austin, H. R., Monsma, F. J. Jr, Sleight, A. J. (1995) Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligodeoxynucleotides. J. Pharmac. Exp. Ther. 274, 173-180.
5. Casey, D. E. (1991) Neuroleptic drug-induced extra-pyramidal syndromes and tardive dyskinesia. Schizophr. Res. 4, 109-120.
6. Creese, I. and Snyder, S. H. (1981) Receptor adaptations to centrally acting drugs. A. Rev. Pharmac. 21, 357-391.
7. Crooke, S. T. (1995) Progress in antisense therapeutics. Hematol. Path. 9, 59-72.
8. Davidkova, G., Zhang, S.-P., Zhou, L.-W., Nichols, R. A. and Weiss, B. (1997) Use of antisense RNA expression vectors in neurobiology. In Antisense Oligodeoxy-nucleotides and Antisense RNA as Novel Pharmacological and Therapeutic Agents, ed. B. Weiss. CRC Press, Boca Raton, FL.
9. Davidkova, G., Zhang, S.-P., Nichols, R. A. and Weiss, B. (1996a) Reduced level of calmodulin in PC 12 cells induced by stable expression of calmodulin antisense RNA inhibits cell growth and induces neurite out growth. Neuroscience 75, 1003-1019.
10. Davidkova, G., Zhou, L.-W., Zhang, S.-P., Morabito, M. and Weiss, B. (1996b) Transfection of D2 dopamine receptor antisense RNA plasmid vector in vitro and in vivo. Soc. Neurosci. Abstr. 22, 1319.
11. De Mesmaeker, A., Haner, R., Martin, P. and Moser, H. E. (1995) Antisense oligonucleotides. Accredit. Chem. Res. 28, 366-374.
12. Ebadi, M. and Hama, Y. (1988) Dopamine, GABA, cholecystokinin and opioids in neuroleptic-induced tardive dyskinesia. Neurosci. Biobehav. Rev. 12, 179-187.
13. Esmaeli-Azad, B., McCarty, J. H. and Feinstein, S. (1994) Sense and antisense transfection analysis of tau function: tau influences net microtuhule assembly, neurite out-growth and neuritic stability. J. Cell Sci. 107, 869-879.
14. Goodale, D. B., Jacobi, A. G. M., Winkler, J. D. and Weiss, B. (1985) Rapid stereotaxic injections into mouse striatum using a plastic mold. Soc. Neurosci. Abstr, 11, 772.
15. 2 dopamine receptor antisense increases the activity and mRNA of tyrosine hydroxylase and aromatic l-amino acid decarboxylase in mouse brain. Neurosci. Lett. 217, 105-108.
16. 2 receptor cDNA into rat striatum. Molec. Brain Res. 34, 315-320.
17. Kane, J. M. (1995) Current problems with the pharmacotherapy of schizophrenia. Clin. Neuropharmac. 18, S154-S161.
18. Kurth, R. (1995) Risk potential of the chromosomal insertion of foreign DNA. Ann. N. Y. Acad. Sci. 772, 140-151.
19. 1 receptors in dyskinesia. Clin. Neuropharmac. 15, 448-458.
20. 2a receptor gene: sequence homology with the rat and human genes and expression of alternative transcripts. J. Neurochem. 57, 795-801.
21. 3 receptors. Molec. Pharmac. 43, 749-754.
22. Nissbrandt, H., Ekman, A., Eriksson, E. and Heilig, M. (1995) Dopamine D3 receptor antisense influences dopamine synthesis in rat brain. NeuroReport 6, 573-576.
23. Peroutka, S. J. and Snyder, S. (1980) Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency. Am. J. Psychiat. 137, 1518-1522.
24. 2 dopamine receptors. J. Neurochem. 62, 411-420.
25. 2 dopamine receptors. Molec. Pharmac. 48, 730-737.
26. Reynolds, G. P. (1996) Dopamine receptors and schizophrenia. Biochem. Soc. Trans. 24, 202-205.
27. Rutka, J. T., Hubbard, S. L., Fukuyama, K., Matsuzawa, K., Dirks, P. and Becker, L. (1994) Effects of antisense glial fibriliary acidic protein complementary DNA on the growth, invasion and adhesion of human astrocytoma cells. Cancer Res. 54, 3267-3272.
28. Sambrook, J., Fritsch, E. F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Press, New York.
29. 2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum. Neurosci. Lett. 74, 180-186.
30. Schinke, M., Bohm, M., Bricca, G., Ganten, D. and Bader, M. (1996) Permanent inhibition of angiotensinogen synthesis by antisense RNA expression. Hypertension 27, 508-513.
31. Seeman, P. (1993) Schizophrenia as a brain disease. Arch. Neurol. 50, 1093-1095.
32. 2 autoreceptors in the motor actions of cocaine. Molec. Pharmac. 46, 51-57.
33. 2 receptor occupancy in schizophrenic patients. Biol. Psychiat. 23, 653-663.
34. Sokoloff, P. and Schwartz, J.-C. (1995) Novel dopamine receptors half a decade later. Trends Pharmac. Sci. 16, 270-275.
35. Standifer, K. M., Chien, C.-C., Wahlestedt, C., Brown, G. and Pasternak, G. W. (1994) Selective loss of delta oipoid analgesia and binding by antisense oligonucleotides to a delta opioid receptor. Neuron 12, 805-810.
36. Trojan, J., Johnson, T. R., Rudin, S. D., Ilan, J. U., Tykocinski, M. and Ilan, J. (1993) Treatment and prevention of rat glioblastoma directed by immunogenic antisense IGF-1 tumor transfectants. Science 259, 94-97.
37. Ungerstedt, U. (1971) Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigrostriatal dopamine system. Acta Psychiatr. Scand. Suppl. 367, 69-93.
38. Von Voigtlander, P. F. and Moore, K. E. (1973) Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-dopa, amantadine, amphetamine and other psychomotor stimulants. Neuropharmacology 12, 451-462.
39. Wang, C. Y. and Huang, L. (1987) pH-Sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse. Proc. Natn. Acad. Sci. U.S.A. 84, 7851-7855.
40. Weiss, B., Zhang, S.-P. and Zhou, E.-W. (1997a) Antisense strategies in dopamine receptor pharmacology. Life Sci. 60, 433-455.
41. Weiss, B., Davidkova, G. and Zhang, S.-P. (1997b) Antisense strategies in neurobiology. Neurochem. Int. 31, 321-348.
42. 2 dopamine receptor mRNA in mouse brain: molecular and behavioral correlates. Adv. Biosci. 77, 9-25.
43. 2 messenger RNA. Neuroscience 55, 607-612.
44. 2 dopaminergic responses. Psychopharmacology 92, 285-291.
45. Winkler, J. D. and Weiss, B. (1986) Reversal of supersensitive apomorphine-induced rotational behavior in mice by con-tinuous exposure to apomorphine. J. Pharmac. Exp. Ther. 238, 242-247.
46. Wong, S. C., Moffat, M. A., Cocker, G. T., Merlie, J. P. and O'Malley, K. L. (1995) The 3′ flanking region of the human tyrosine hydroxylase gene directs reporter gene expression in peripheral neuroendocrine tissues. J. Neurochem. 65, 23-31.
47. 2 receptors: behavioral correlates. Neurosci. Lett. 161, 223-226.
48. 1 dopamine receptor-mediated behaviors in normal mice and in mice lesioned with 6-hydroxydopamine. J. Pharmac. Exp. Ther. 271, 1462-1470.
49. 2 dopamine receptor antisense RNA vector transfected in mouse brain. Soc. Neurosci. 22, 1318.
50. 2 dopamine receptors in mouse striatum. J. Pharmac. Exp. Ther. 268, 1015-1023.
51. Zhu, N., Liggitt, D., Liu, Y. and Debs, R. (1993) Systemic gene expression after intravenous DNA delivery into adult mice. Science 261, 209-211.